Share

September 2019; 6 (5) EditorialOpen Access

Blood neurofilament light chain at the doorstep of clinical application

David Leppert, Jens Kuhle
First published August 9, 2019, DOI: https://doi.org/10.1212/NXI.0000000000000599
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
964

Share

Article Information

vol. 6 no. 5 e599
DOI: 
https://doi.org/10.1212/NXI.0000000000000599
PubMed: 
31516914
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Online ISSN: 
2332-7812
History: 
  • First Published August 9, 2019.
Copyright & Usage: 
Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

Author Disclosures

    1. David Leppert, MD and
    2. Jens Kuhle, MD, PhD
  1. David Leppert, MD and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel cost reimbursement and speaker honoraria from Sanofi and Orion

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. David Leppert has been a Novartis employee until January 2019.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. David leppert has been a Novartis employee until January 2019.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Jens Kuhle, MD, PhD
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Bayer AG (2) Biogen (3) Celgene (4) Genzyme (5) Merck (4) Novartis (5) Roche Pharma (Schweiz) AG

    Research Support, Government Entities:

    1. (1) Swiss National Research Foundation

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) ECTRIMS Research Fellowship Programme (2) University of Basel (3) Swiss MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Neurologic Clinic and Policlinic, Departments of Medicine, Biomedicine and Clinical Research, University Hospital and University of Basel, Basel, Switzerland.
  1. Correspondence
    Dr. Kuhle jens.kuhle{at}usb.ch or Dr. Leppert david.leppert{at}unibas.ch

Article usage

Article usage: August 2019 to October 2023

AbstractFullPdfSource
Aug 2019324249Highwire
Sep 20195419143Highwire
Oct 2019910133Highwire
Nov 201975528Highwire
Dec 2019013524Highwire
Jan 202026817Highwire
Feb 202025521Highwire
Mar 202017618Highwire
Apr 202004713Highwire
May 202015416Highwire
Jun 202004715Highwire
Jul 202013211Highwire
Aug 202013714Highwire
Sep 202033514Highwire
Oct 202004913Highwire
Nov 202013322Highwire
Dec 202013114Highwire
Jan 202113722Highwire
Feb 202102813Highwire
Mar 202103815Highwire
Apr 20212288Highwire
May 20210358Highwire
Jun 20211329Highwire
Jul 202102819Highwire
Aug 202114128Highwire
Sep 202102119Highwire
Oct 202104337Highwire
Nov 202104334Highwire
Dec 202104625Highwire
Jan 202202518Highwire
Feb 202213011Highwire
Mar 20221249Highwire
Apr 202203619Highwire
May 202202914Highwire
Jun 202202110Highwire
Jul 20220258Highwire
Aug 202223811Highwire
Sep 202203514Highwire
Oct 202204216Highwire
Nov 202216626Highwire
Dec 20220348Highwire
Jan 202303613Highwire
Feb 202303213Highwire
Mar 202302011Highwire
Apr 202302211Highwire
May 202301910Highwire
Jun 20230176Highwire
Jul 20230178Highwire
Aug 202301510Highwire
Sep 20230227Highwire
Oct 20230179Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. [email protected]
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Topics Discussed

Alert Me

Recommended articles